Cerebral venous pressure during actively induced hypertension and hypercapnia in cats

Monitoring of intracranial pressure and cerebral hemodynamics by transjugular dural sinus catheterization

Cerebral venous sampling may be useful in the evaluation of cerebral damage. A catheter was successfully inserted 18 cm deep from the right internal jugular vein into the transverse sinus in a 38 year old man with B-mode ultrasound guidance to measure pressure and sample blood. Transverse sinus venous oxygen saturation (StvO2) was lower than normal ranges (55% - 75%) for jugular venous oxygen saturation (SjvO2). At the time spontaneous cardiac rhythm was restored, transverse sinus pressure increased briefly to 26 mmHg [more than 15 mmHg higher than normal intracranial pressure (ICP)]. This case suggests that catheterization of the dural sinus may be accomplished with B-mode ultrasound guidance and that the catheter can be used to monitor ICP and cerebral hemodynamics.

PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists have been shown to protect the cerebral vasculature, including the blood-brain barrier. In the present study, we investigated the effect of the PPAR-gamma agonist rosiglitazone on changes in venous permeability during chronic hypertension induced by nitric oxide synthase inhibition. Female Sprague-Dawley rats were either treated with N(G)-nitro-L-arginine methyl ester (L-NAME; 0.5 g/l in drinking water) for 5 wk (HTN; n = 8), L-NAME for 5 wk plus the PPAR-gamma agonist rosiglitazone (20 mg/kg in food) for the last 3 wk (HTN + Rosi; n = 5), L-NAME for 5 wk plus the superoxide dismutase mimetic Tempol (1 mmol/l in drinking water) for the last 3 wk (HTN + Tempol; n = 8), or were untreated controls (n = 9). Fluid filtration (J(v)/S) and hydraulic conductivity (L(p)) of cerebral veins were compared in vitro between groups after a step increase in pressure from 10 to 25 mmHg to mimic the change in hydrostatic pressure during acute hypertension. Hypertension increased J(v)/S by 2.2-fold and L(p) by 3.2-fold. Rosiglitazone treatment after 2 wk of hypertension completely reversed the increased J(v)/S and L(p) that occurred during hypertension, whereas Tempol had no effect. These results demonstrate that rosiglitazone was effective at reversing changes in venous permeability that occurred during chronic hypertension, an effect that does not appear to be related to its antioxidant properties. Our findings suggest that PPAR-gamma may be a key regulator of blood-brain barrier permeability and a potential therapeutic target during hypertension.

Intravenous infusion of cereport increases uptake and efficacy of acyclovir in herpes simplex virus-infected rat brains

The outcome of herpes simplex virus (HSV) infections manifesting as encephalitis in healthy or immunocompromised individuals is generally very poor with mortality rates of about 8 to 28% with treatment. The long-term prognosis of survivors is often problematic, posing the need for alternative treatments that may decrease the mortality and morbidity associated with herpes encephalitis. This study addresses one such approach that includes a temporary permeabilization of the blood-brain barrier during treatment with acyclovir (ACV). In these studies we utilized a synthetic bradykinin analog, Cereport (RMP-7), in conjunction with ACV to treat HSV infection of the brain in a rat model. Cereport, infused intravenously via the jugular vein, was shown to increase [(14)C]ACV uptake in both the HSV-1-infected and -uninfected rat brain by approximately two- to threefold, correlating with enhanced efficacy of ACV in various brain compartments. In another series of experiments to determine efficacy, various doses of unlabeled ACV were administered during infusion with RMP-7. The decrease in viral titers in the temporal regions of the brain after 5 days of treatment suggested that this approach enhanced the efficacy of ACV treatment. These data indicated that Cereport infused with ACV enhances both the penetration and efficacy of this drug in the treatment of an experimental HSV-1 infection of the rat brain.

Effects of duration of positive-pressure ventilation on blood-brain barrier function in premature lambs

We have been studying the ontogeny of the blood-brain barrier function in ovine fetuses and lambs. During these studies, we have found that the duration of ventilation also influences blood-brain barrier permeability in premature lambs. Chronically instrumented hysterotomy-delivered surfactant-treated premature lambs were studied at 90% or 137 days of gestation (n = 9). Blood-brain barrier function was quantified with the blood-to-brain transfer constant K(i) to alpha-aminoisobutyric acid. Linear regression analysis was used to compare the K(i) values in the brain regions, as the dependent variable, to the duration of ventilation, as the independent variable. There were direct correlations (P < 0.05) between the K(i) values and the duration of ventilation [306 min (mean), 162-474 min (range)] in the cerebral cortex, cerebellum, medulla, caudate nucleus, hippocampus, superior colliculus, inferior colliculus, thalamus, pons, cervical spinal cord, and choroid plexus, but not in the pituitary gland. Ventilatory pressures and rates were established before the onset of the permeability studies. Calculated mean airway pressures [14 cmH(2)O (mean), 7-20 cmH(2)O (range)] from similarly studied premature lambs did not correlate with the duration of positive-pressure ventilation. We conclude that increases in the duration of positive-pressure ventilation predispose premature lambs to increases in regional blood-brain barrier permeability. These alterations in barrier function occur over relatively short time intervals (minutes to hours). In our study, these changes in permeability are most likely not attributable to changes in mean airway pressure.

Differences in contrast enhancement between intra- and extra-axial lesions after two hours of iodine injection

In order to try to improve discrimination between the brain lesions that produce damage to the brain-blood barrier and those which are irrigated by extracerebral vessels, the behavior of contrast enhancement up to two hours after iodine injection was studied in two groups of patients. Eight patients had extra-axial lesions (7 meningiomas, one acoustic neuroma) and eleven had intra-axial lesions (6 of astrocytic type, 3 metastases, 2 inflammatory). In the first group, mean values of the lesioned areas in HU decreased progressively with time. However, in many cases in the second group the values at the end of the study were equal to or higher than those observed immediately after contrast medium injection. Highly significant differences were observed between the two groups. The contrast medium in the intra-axial lesions conform to the behavior of all other fluids in a damaged barrier, remaining for a very long time in the interstitial space. In the extra-axial lesions, the contrast moved freely and the return from the interstitial to the intravascular space was also unobstructed, since values decayed immediately after injection. For these reasons, the observation of scans after two hours of contrast injection might be useful for differential diagnosis in those cases where doubt exists.

Effect of intracranial pressure on bridging veins in rats

The behavior of bridging veins at their entrance into the superior sagittal sinus during elevated intracranial pressure (ICP) was investigated in rats using a cranial window and infusion of mock cerebrospinal fluid. The bridging veins became slightly smaller as the ICP rose (maximum reduction 17%). Compression or collapse of the veins was not observed, even at an ICP level of 100 mm Hg, and there was no cuffing of bridging veins upstream of the entrance. Both the scanning electron microscopic investigation based on resin vessel casts and the histological examination of whole-head coronal sections indicated that the narrowest points of the bridging veins are at their entrance to the superior sagittal sinus, caused by the oval aperture with thickened wall structure in the lateral sinus wall to which the bridging veins are connected. The present data thus support the concept that cerebral blood flow during intracranial hypertension is not reduced by venous cuffing or compression of the lateral lacunae and bridging veins; by contrast, the arteriovenous pressure difference seems to remain the determining factor even at high ICP. Thus, blood flow through the brain stops when ICP approaches the level of blood pressure.

Role of veins and cerebral venous pressure in disruption of the blood-brain barrier

The goal of this study was to determine whether increases in cerebral venous pressure contribute to, and may account for, disruption of the blood-brain barrier during acute hypertension and hyperosmolar stimuli. We studied the relation between pial venous pressure and disruption of the blood-brain barrier during acute arterial hypertension, superior venae cavae occlusion, and superfusion with hyperosmolar arabinose. Sprague-Dawley rats were studied using intravital fluorescent microscopy and fluorescein-labelled dextran (mol. wt. = 70,000). Disruption of the blood-brain barrier was characterized by the appearance of microvascular leaky sites and quantitated by the clearance of fluorescein dextran. We measured pressure (servo null) in pial arterioles and venules 40-60 micron in diameter. Acute hypertension, occlusion of the superior venae cavae, and hyperosmolar arabinose produced leaky sites primarily in venules. Acute hypertension increased arteriolar pressure and also venular pressure, from 7 +/- 1 (mean +/- SE) to 28 +/- 2 mm Hg. Clearance of fluorescein dextran increased from 0.03 +/- 0.01 to 2.90 +/- 0.40 ml/sec X 10(-6). Occlusion of the superior venae cavae increased pial venous pressure from 7 +/- 1 to 30 +/- 3 mm Hg, and clearance of fluorescein dextran, from 0.02 +/- 0.01 to 3.10 +/- 0.59 ml/sec X 10(-6). In contrast to acute hypertension, there was a decrease in arterial and pial arteriolar pressure during occlusion of the superior venae cavae. Thus, similar increases in venous pressure during acute hypertension and superior venae cavae occlusion, despite directionally opposite changes in arterial and arteriolar pressure, produced similar disruption of the blood-brain barrier.(ABSTRACT TRUNCATED AT 250 WORDS)